The Human Papillomavirus Vaccine as a Treatment 1 for HPV-related Dysplastic and Neoplastic Conditions: A Literature Review.

@article{Pham2019TheHP,
  title={The Human Papillomavirus Vaccine as a Treatment 1 for HPV-related Dysplastic and Neoplastic Conditions: A Literature Review.},
  author={Christine T. Pham and Margit L.W. Juh{\'a}sz and Calvin T. Sung and Natasha Atanaskova Mesinkovska},
  journal={Journal of the American Academy of Dermatology},
  year={2019}
}
View on PubMed
doi.org
14 Citations
Highly Influential Citations
1
Background Citations
5
Results Citations
1

14 Citations

Citation Type

Citation Type

Nonavalent Human Papillomavirus Vaccination as a Treatment for Skin Warts in Immunosuppressed Adults: A Case Series.
TLDR
Treatment outcomes using a nonavalent HPV vaccine in immunosuppressed patients with recalcitrant warts are investigated to investigate their use as a treatment for existing HPV-related cutaneous and/or mucosal conditions.
Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial
TLDR
The efficacy of HPV vaccination in addition to LEEP treatment is evaluated to prevent residual or recurrent cervical dysplasia and decrease risks of repeated surgical treatment.
Nonavalent human papillomavirus vaccination as alternative treatment for genital warts
TLDR
Five cases of recalcitrant genital warts that responded well to treatment with the nonavalent HPV vaccine are reported, indicating that HPV vaccines could be beneficial as a noninvasive treatment alternative for recalcitrants genital wwarts.
Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature
TLDR
A review of diseases with susceptibility to HPV provides clues to understanding the pathophysiology of warts and diagnostic guidance is presented to facilitate the recognition of inborn errors of immunity in patients with extensive and/or recalcitrant HPV infections.
Papillomaviruses in Domestic Cats
TLDR
The PV life cycle and the subsequent immune response is briefly discussed along with methods used to investigate a PV etiology of a lesion, and the seven PV types that are currently known to infect cats are reviewed.
The management of penile intraepithelial neoplasia (PeIN): clinical and histological features and treatment of 345 patients and a review of the literature
TLDR
Clinical management of PeIN can be rationally optimized with excellent outcomes, and circumcision is important.
Cold Atmospheric Pressure Plasma (CAP) as a New Tool for the Management of Vulva Cancer and Vulvar Premalignant Lesions in Gynaecological Oncology
TLDR
Cold atmospheric plasma (CAP) treatment is a promising option for VC, and is particularly appropriate for the local treatment of dysplastic lesions, early intraepithelial cancer, and invasive tumours, as well as reducing inflammatory complications and improving wound healing.
Recent Progress in Electrochemical Detection of Human Papillomavirus (HPV) via Graphene-Based Nanosensors
TLDR
Some recent progress in electrochemical detection of HPVs using graphene-based nanosensors is reported and summarized.
Formulation of HBsAg in Montanide ISA 51VG adjuvant: Immunogenicity study and monitoring long-lived humoral immune responses.
Sexually Transmitted Infections of the Colon and Rectum
...
...

References

SHOWING 1-10 OF 68 REFERENCES
Association of Human Papillomavirus Vaccine With the Development of Keratinocyte Carcinomas
TLDR
Findings highlight the possibility that cutaneous SCC development, and perhaps BCC development, may be driven in part by HPV in immunocompetent patients and human papillomavirus vaccination may represent an efficacious, cost-effective, readily available, and well-tolerated strategy for preventing KCs.
A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil®)
  • V. A. Govan
  • Biology, Medicine
    Therapeutics and clinical risk management
  • 2008
TLDR
Data from the Phase III trial demonstrated that Gardasil was 100% effi cacious in preventing precancerous lesions of the cervix, vulva, and vagina and effective against genital warts and it is expected to reduce the incidence of these type specifi c HPV-induced diseases in the future.
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia.
TLDR
Clinical responses in women with HPV- 16-positive, grade 3 vulvar intraepithelial neoplasia can be achieved by vaccination with a synthetic long-peptide vaccine against the HPV-16 oncoproteins E6 and E7.
Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.
TLDR
The results suggest that theTA-HPV vaccine may have an effect on HPV-positive vulval intraepithelial neoplasia/vaginal intraepIThelial neoperasia and that additional studies are warranted to develop an effective therapeutic vaccine.
Combined Systemic and Intratumoral Administration of Human Papillomavirus Vaccine to Treat Multiple Cutaneous Basaloid Squamous Cell Carcinomas
TLDR
This is the first report, to the authors' knowledge, of complete regression of a cutaneous malignant tumor after combined systemic and direct intratumoral injection of the 9-valent HPV vaccine.
Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin.
TLDR
A role for HPV types from the genus beta in the pathogenesis of SCC is supported, and individuals with tumors on chronically sun exposed sites were more likely to be seropositive for beta HPV types than individuals with SCC at other anatomic sites.
Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature
TLDR
It is revealed that current evidence for the effectiveness of therapeutic HPV4 and other adjuvant therapies for JoRRP is inconsistent and the prophylactic use of currently available HPV vaccine for adolescents is the most effective strategy for preventing not only anogenital cancers but also genital warts.
Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients.
Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
Regression of human papillomavirus intraepithelial lesions is induced by MVA E2 therapeutic vaccine.
TLDR
The data suggest that therapeutic vaccination with MVA E2 vaccine is an excellent candidate to stimulate the immune system and generate regression in intraepithelial lesions when applied locally.
...
...